Sinis Cancer hospitalis mercedem Nobel Laureate Professor Craigc.melloas princeps Scientist 

On June 8-9, Professor Craig Melo, a Nobel laureate in Physiology or Medicine, and Professor Jiang Wei from the Cancer Hospital of the Chinese Academy of Medical Sciences visited Dongping, Shandong and participated in the “Nobel Medical Prize Oncology Academic Exchange Conference” hosted by Taimei Baofa Cancer Hospital for in-depth academic exchange. Hoc iter marcas substantial integration eius Nobel Prize blandit RNA intercessiones technology et hospitalis scriptor innovative "tardus-release Library Therapy", injicere fortis momentum in global cancer curatio agro, praesertim pancreaticum cancer curatio.

In MMXVI, Professor Merleau valde laudatur Professor Yu Baofa, in Director of Taimei Baofa Cancer hospitalis, ad inventing "umipic" ad "tertius Nobel Laurete Medical". Postquam novem annis, hoc dialogus originem ex Top International Academic Platforms mos permanere scribere novum capite in Dongping, Shandong. Professor meiluo est visita non solum altum dialogo inter International Cutting-Edge scientific conceptibus et domesticis innovation in Sina, sed etiam novum pontem cooperante in tumore investigationis inter Sina et aliena regionibus.

In commutatione testimonii, professor Melo participatur eius tardus insights in agro RNA intercessiones et tumore investigationis. Professor Jiang Wei from the Cancer Hospital of the Chinese Academy of Medical Sciences shared 《Art of Cancer Research: Applications of RNAi, Animal Models and Super Resolution Imaging》.Academician Yu Baofa shared clinical research on self nano induced tumor immunotherapy for solid tumors at the exchange meeting, and shared 27 years of clinical experience in using sustained-release drug therapy to treat cancer. Antequam in commutationem testimonii coepit, professor Merleau et professor Yu Baofa pervenit cancer investigationis cooperante consensu et libenter accepit appointment of dux physicus de Baofa medicinae. Professor Yu Baofa presented donum ad Professor Merleau - A Merleau Portrait oleum pictura signati ab Professor Yu Baofa. Et perfectum compositum Nobel laureate RNA intercessiones technology et professor Yu Baofa scriptor patented technology "sustinuit, release Library" est maxima benedictione ad cancer aegris. Hoc commutationem erit in platform pro collectio global Sapientia et collidentes innovative scintillae et eius secans-ore scientifica perspective expectat ut designandum de breakthrough directiones pro domesticis oncology civitatem.

Cum suam instauratione XXVII annos, Taimei Boofa cancer hospitalis habet effectum significant results in usum "umipic" pro chemotherapy et immunotherapy in tumores, praesertim pro pancreatager cancer. Hoc est in "orci operationem guidelines ad interventional Lorem provectus pancreaticum cancer" (Trial) (Latin Edition). Tamen, illic es adhuc singula differentias in medicinales efficaciam in ipsa orci usu, et Yu Baofa quadrigis identified radix causa differentiae. Professor Merleau est consideratum Nobel Prize ad Co Devovering RNA intercessiones cum Andrew Farr in MMVI. Hoc inventa reveals Core mechanism per quod duplex, foramen ascenderunt in scilicet inhibere gene. RNA intercessiones technology factus est in angulari instrumentum in moderni biomedical investigationis, providing novum ideas ad curatio variis morbis inter cancer. Professor Melo est RNA intercessiones technology est expectata ad verius solvere hoc problema et significantly amplio consistency in medicinales efficaciam. Et technica integration utrinque non solum a major breakthrough in curatio pancreatic cancer in mundo, sed etiam erit comprehendendo emendare therapeutica effectus "tardus release Library Therapy" in omni solido.

Ex academic resonatur in MMXVI ad current technica implementation, hoc collaboration est exemplum abyssi integration inter Internationalis Top Scientific Research res gestae et Chinese C. Practice. Ut aestimari per GU Fangzhou, pristini Praeses Peking Unionis Medical College, Professor Yu Baofa habet "pioneered scientificis investigationis privatorum hospitalium". Introduction of Professor Melo scriptor technology non solum amplio campester of tumor curatio in loci et ambiente locis, sed etiam ignite novum Aurora vitae ad cancer aegros terrarum et promovere humanum anti-cancer causa ad novum altitudo. Ante trinus, Professor Mervéau etiam specie dicta scientiam non novit terminos et pugnando cancer requirit global sapientia. "Ego vultus deinceps in-profundum cooperante cum Professor Yu Boofa scriptor quadrigis ad explorandum efficax cancer solutions simul.